KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xenon Pharmaceuticals (XENE) Tax Provisions: 2018-2024

Historic Tax Provisions for Xenon Pharmaceuticals (XENE) over the last 7 years, with Dec 2024 value amounting to $4.8 million.

  • Xenon Pharmaceuticals' Tax Provisions rose 311.56% to $677,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year increase of 1331.84%. This contributed to the annual value of $4.8 million for FY2024, which is 1735.27% up from last year.
  • Xenon Pharmaceuticals' Tax Provisions amounted to $4.8 million in FY2024, which was up 1,735.27% from -$292,000 recorded in FY2023.
  • In the past 5 years, Xenon Pharmaceuticals' Tax Provisions ranged from a high of $4.8 million in FY2024 and a low of -$292,000 during FY2023.
  • Over the past 3 years, Xenon Pharmaceuticals' median Tax Provisions value was $162,000 (recorded in 2022), while the average stood at $1.5 million.
  • In the last 5 years, Xenon Pharmaceuticals' Tax Provisions tumbled by 1,017.39% in 2020 and then skyrocketed by 2,800.00% in 2022.
  • Xenon Pharmaceuticals' Tax Provisions (Yearly) stood at -$257,000 in 2020, then soared by 97.67% to -$6,000 in 2021, then skyrocketed by 2,800.00% to $162,000 in 2022, then crashed by 280.25% to -$292,000 in 2023, then surged by 1,735.27% to $4.8 million in 2024.